Although we previously demonstrated that disruption of CCR1-mediated myeloid cell accumulation suppressed tumor progression in syngeneic mouse models [13], it remains unclear whether disruption of CXCR2-mediated myeloid cell accumulation can suppress tumor progression. This evidence concerns the gene CCR1 and neoplasm.